Klor-con and Xopenex hfa drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Klor-con (potassium chloride) and Xopenex hfa (levalbuterol tartrate). Common drug interactions include peripheral swelling among females and swelling face among males.

The phase IV clinical study analyzes what interactions people have when they take Klor-con and Xopenex hfa. It is created by eHealthMe based on reports of 67 people who take the same drugs from the FDA, and is updated regularly.

What is Klor-con?

Klor-con has active ingredients of potassium chloride. It is often used in hypokalemia. eHealthMe is studying from 27,547 Klor-con users. Check the latest studies of Klor-con.

What is Xopenex hfa?

Xopenex hfa has active ingredients of levalbuterol tartrate. It is often used in asthma. eHealthMe is studying from 2,529 Xopenex hfa users. Check the latest studies of Xopenex hfa.



On Jul, 06, 2026

67 people who take Klor-con and Xopenex hfa together, and have interactions are studied.

Klor-con and Xopenex hfa drug interactions.

What are the common drug interactions of Klor-Con and Xopenex Hfa, by gender? *:

female:

  1. Peripheral swelling
  2. Pharyngitis (inflammation of the pharynx, causing a sore throat)
  3. Pollakiuria (abnormally frequent passage of relatively small quantities or urine)
  4. Rash macular (small, flat red spots)
  5. Rash pruritic (redness with itching)
  6. Seasonal allergy (allergic condition due to certain season)
  7. Sleep disorder
  8. Staphylococcal infection (an infection with staphylococcus bacteria)
  9. Tremor (trembling or shaking movements in one or more parts of your body)
  10. Upper-airway cough syndrome

male:

  1. Swelling face
  2. Anxiety
  3. Arrhythmia (irregular heartbeat)
  4. Balance disorder
  5. Chronic kidney disease
  6. Cough
  7. Dandruff
  8. Death
  9. Dehydration (dryness resulting from the removal of water)
  10. Drug hypersensitivity

What are the common drug interactions of Klor-Con and Xopenex Hfa, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Corneal dystrophy (abnormal deposition of substances in the transparent front part of the eye)
  2. Headache (pain in head)
  3. Insomnia (sleeplessness)
  4. Muscle tightness
  5. Asthenia (weakness)
  6. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  7. Constipation
  8. Drug ineffective
  9. Dyspnoea (difficult or laboured respiration)
  10. Ear infection

50-59:

  1. Osteoarthritis (a joint disease caused by cartilage loss in a joint)
  2. Pain
  3. Paranasal sinus discomfort
  4. Peripheral swelling
  5. Poor quality sleep
  6. Radiculopathy (a set of conditions in which one or more nerves is affected and does not work properly)
  7. Restlessness (not able to rest)
  8. Sinusitis bacterial (bacterial infection of sinus)
  9. Sleep disorder
  10. Dyspnoea (difficult or laboured respiration)

60+:

  1. Fatigue (feeling of tiredness)
  2. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  3. Upper-airway cough syndrome
  4. Abdominal discomfort
  5. Arrhythmia (irregular heartbeat)
  6. Asthenia (weakness)
  7. Balance disorder
  8. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  9. Blood potassium decreased
  10. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 16 people, 23.88%
  2. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 13 people, 19.40%
  3. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 9 people, 13.43%
  4. Pain: 7 people, 10.45%
  5. High Blood Cholesterol: 7 people, 10.45%
  6. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 8.96%
  7. Drowsiness: 6 people, 8.96%
  8. Type 2 Diabetes: 5 people, 7.46%
  9. Migraine (headache): 5 people, 7.46%
  10. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 5 people, 7.46%

* Approximation only. Some reports may have incomplete information.

Do you take Klor-con and Xopenex hfa?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Klor-con and Xopenex hfa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Klor-con:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Xopenex hfa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Klor-con and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Xopenex hfa and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on potassium chloride and levalbuterol tartrate (the active ingredients of Klor-con and Xopenex hfa, respectively), and Klor-con and Xopenex hfa (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: